Delivery Order SPE2DB22D1017-SPE2DB25FYRGK
Award Date 9/18/25
Potential Completion Date 9/19/25
Potential Value $20K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (100-count unit dose packages) on October 29, 2025, with a ceiling value of $1,146.60 and completion date of October 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. UBRELVY is a migraine treatment medication, representing one of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,270.92 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (10-count unit dose packaging) with an ultimate completion date of August 1, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open process. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. UBRELVY is a migraine treatment medication,...
- The Defense Logistics Agency awarded a delivery order valued at $12,287.77 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (10 unit dose packages) on November 5, 2025, with completion scheduled for November 6, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. UBRELVY is a prescription medication used for migraine treatment, representing one of...
- The Defense Logistics Agency awarded a delivery order valued at $2,199.96 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (10 unit dose packages) on August 14, 2025, with an ultimate completion date of August 15, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December...
- The Defense Logistics Agency awarded a $15,567.60 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of UBRELVY 100 mg tablets (unit dose, 10s). This is a firm fixed price, competitively awarded contract with an ultimate completion date of August 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. UBRELVY is a prescription migraine treatment, indicating this delivery order supports military or federal...
- The Defense Logistics Agency awarded a $13,759.20 delivery order to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (10-count unit dose packages) with a completion date of September 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award was made on September 19, 2025, with performance occurring at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $30,259.15 to AmerisourceBergen Drug Corp for UBRELVY 100 MG tablets (16-count units) on October 30, 2025, with an ultimate completion date of November 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. UBRELVY is a prescription medication used for acute migraine treatment, reflecting the federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,179.09 for UBRELVY 100 mg tablets (10-unit dose packaging) on October 20, 2025, with completion scheduled for October 21, 2025. This is a firm fixed price contract with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $42,518.73 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (16-count unit dose packaging) on August 14, 2025, with completion targeted for August 15, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. UBRELVY is a migraine treatment medication, reflecting the broad...
- The Defense Logistics Agency awarded a delivery order valued at $15,435.98 to AmerisourceBergen Drug Corp for the supply of UBRELVY 100 mg tablets (10 unit dose packages) on November 5, 2025, with an ultimate completion date of November 6, 2025. This is a firm fixed price, non-set-aside delivery order performed at the contractor's facility in Conshohocken, Pennsylvania. UBRELVY is a migraine treatment medication, representing one component of AmerisourceBergen's extensive pharmaceutical supply...